Bionano Genomics Inc. (BNGO) is priced at $5.86 after the most recent trading session. At the very opening of the session, the stock price was $5.69 and reached a high price of $5.98, prior to closing the session it reached the value of $5.88. The stock touched a low price of $5.66.Recently in News on August 26, 2021, Bionano Genomics Announces ESHG Lineup Featuring 11 Customer Presentations of OGM Data Spanning Three Major Clinical Research Areas of Application from 10 Institutions and Six Countries. Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the European Society of Human Genetics (ESHG) conference lineup featuring 11 customer presentations of optical genome mapping (OGM) data spanning three major clinical areas of application from 10 institutions and six countries. The clinical application areas represented below cover hematological malignancies, inherited genetic disorders and solid tumor analysis. The presentations are expected to cover the clinical utility of OGM across these application areas, along with the unique capabilities of Bionano’s Saphyr® system to detect all classes of structural variants, across the genome, at a superior resolution relative to traditional techniques. The ESHG conference is being held virtually starting this Saturday from August 28 – 31, 2021. You can read further details here
Bionano Genomics Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $15.69 on 02/16/21, with the lowest value was $3.91 for the same time period, recorded on 01/08/21.
3 Tiny Stocks Primed to Explode The world’s greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We’ve set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Bionano Genomics Inc. (BNGO) full year performance was 833.33%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Bionano Genomics Inc. shares are logging -62.67% during the 52-week period from high price, and 1136.98% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.47 and $15.69.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 2392411 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Bionano Genomics Inc. (BNGO) recorded performance in the market was 90.91%, having the revenues showcasing -4.70% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 1.58B, as it employees total of 147 workers.
Specialists analysis on Bionano Genomics Inc. (BNGO)
During the last month, 0 analysts gave the Bionano Genomics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 6.27, with a change in the price was noted -1.76. In a similar fashion, Bionano Genomics Inc. posted a movement of -23.37% for the period of last 100 days, recording 18,158,320 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for BNGO is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Trends and Technical analysis: Bionano Genomics Inc. (BNGO)
Raw Stochastic average of Bionano Genomics Inc. in the period of last 50 days is set at 21.10%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 52.00%. In the last 20 days, the company’s Stochastic %K was 52.27% and its Stochastic %D was recorded 52.44%.
Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 90.91%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -40.24%, alongside a boost of 833.33% for the period of the last 12 months. The shares increased approximately by 9.09% in the 7-day charts and went up by -3.45% in the period of the last 30 days. Common stock shares were lifted by -4.70% during last recorded quarter.